Frequently Asked Questions

The Profend Nasal Decolonization Kit can be used anywhere in a healthcare facility where there are patients who may be nasally colonized with S. aureus or MRSA and therefore have an elevated risk of developing an SSI or other HAIs.

Sani-HyPerCide® Germicidal Disposable Spray (EPA reg number 9480-14), Sani-HyPerCide® Germicidal Wipes (EPA reg number 9480-16), Sani-Cloth® Prime Germicidal Disposable Wipes (EPA reg number 9480-12), Sani-Prime™ Germicidal Spray (EPA reg number 9480-10), Sani-Cloth® AF3 Germicidal Disposable Wipes (EPA reg number 9480-9), Super Sani-Cloth® Germicidal Disposable Wipes (EPA reg number 9480-4) and Sani-Cloth® Bleach Germicidal Disposable Wipes (EPA reg number 9480-8) have an efficacy claim against Mycobacterium bovis (i.e. Tuberculosis), qualifying these products as intermediate-level disinfectants. Each product exceeds the CDC’s recommendations for cleaning and disinfection in healthcare facilities. Sani-Cloth® Plus wipes (EPA reg number 9480-6) and Sani-Cloth® HB wipes (EPA reg number 61178-4-9480) do not have an efficacy claim against Mycobacterium bovis, which classifies these products as low-level disinfectants.

All of PDI’s Sani-Cloth® brand products are EPA-Registered. Sani-HyPerCide® Germicidal Disposable Spray (EPA reg number 9480-14), Sani-HyPerCide® Germicidal Wipes (EPA reg number 9480-16), Sani-24® Germicidal Spray (EPA reg number 42182-9-9480), Sani-24® Germicidal Wipes (EPA reg number 42182-13-9480), Sani-Cloth® Prime Germicidal Disposable Wipes (EPA reg number 9480-12), Sani-Prime™ Germicidal Spray (EPA reg number 9480-10), Sani-Cloth® AF3 Germicidal Disposable Wipes (EPA reg number 9480-9), Super Sani-Cloth® Germicidal Disposable Wipes (EPA reg number 9480-4) and Sani-Cloth® Bleach Germicidal Disposable Wipes (EPA reg number 9480-8) have an efficacy claim against Mycobacterium bovis (i.e. Tuberculosis), qualifying these products as intermediate-level disinfectants. Each product exceeds the CDC’s recommendations for cleaning and disinfection in healthcare facilities. Sani-Cloth® Plus wipes (EPA reg number 9480-6) and Sani-Cloth® HB wipes (EPA reg number 61178-4-9480) do not have an efficacy claim against Mycobacterium bovis, which classifies these products as low-level disinfectants.

The contact time listed on the product label is the total amount of time that it takes to inactivate ALL of the microorganisms listed on the product label. This time is typically referred to in minutes, and should be communicated to staff members that are utilizing the disinfectant. In certain geographies and also in settings where temperature, relative humidity, and air changes may vary, it is possible that the surface may not remain visibly wet for the designated contact time. Current EPA guidance requires that the treated environmental surface or equipment remains wet for the contact time stated on product label. Additional wipes may be needed in order to comply with the EPA guidance, however the overall contact time does not change.

While the EPA requires the treated environmental surfaces to remain wet for the stated contact time, leading researchers in infection prevention offer an alternate view. In a commentary published in Infection Control and Hospital Epidemiology (March 2018, vol. 39, no. 3, pp 229-331), Dr. W.A. Rutala and Dr. D. J. Weber suggest that contact time and treatment time are mutually exclusive. They suggest that treatment time, irrelevant of wet time, should be followed by healthcare workers for wipes and sprays (except bleach products.) PDI will continue to monitor the science closely and provide their customers with the latest information as federal law permits.

Most Sani-Cloth® brand products can be shipped via air transportation. However, Sani-24® and Sani-Prime sprays, as well as Sani-Cloth Prime wipes, Super Sani-Cloth wipes and Sani-Cloth Plus wipes cannot be shipped by air due to shipping regulations. These products are shipped via ground transportation only.

PDI disinfectants DO NOT contain any ingredients listed as a carcinogenic by the National Toxicology Program (NTP), American Conference of Governmental Industrial Hygienists (ACGIH), and Occupational Safety and Health Administration (OSHA). To register any disinfectant product with the US Environmental Protection Agency (EPA), the manufacturer is required to provide the EPA with the product’s manufacturing process, active and inactive ingredients, efficacy, chemistry, toxicity, and information about relevant impurities. The EPA conducts a thorough review of these materials and product’s ingredients. The agency would not register any product if it contained carcinogens without requiring relevant label warnings (40 CFR 156.10(g)(7)). As such, Sani-Cloth® Wipes and Sani-Prime™ Spray do not contain carcinogenic label warnings.

NFPA 30 applies to the storage of flammable and combustible liquids. PDI products, including Sani-HyPerCide® wipes and spray, Sani-24® spray, Sani-Cloth® Prime wipes, Super Sani-Cloth wipes, and Sani-Cloth Plus cloth, as well as Easy Screen® Cleaning Wipe, are exempt from the requirements of NFPA 30. This is because the scope of NFPA 30 (Section 1.1) states that it applies to the storage, handling, and use of flammable and combustible liquids. Even though our products contain liquids that have been classified as flammable on the SDS, the wipes themselves are not classified as liquid products. Rather, they are wipes impregnated with flammable liquids, even though there may be a small amount of free liquid in the bottom of the canister. According to the EPA, wipes are classified as a mixture product containing solids and liquids. The NFPA has also confirmed that wipes are not considered to be liquid for the purposes of NFPA 30. In addition, NFPA Section 9.1.4(4) states that it does not apply to “medicines, foodstuffs, cosmetics and other consumer products that contain more than 50 percent by volume of water-miscible liquids, with the remainder of the solution not being flammable where packaged in individual containers that do not exceed 5L (1.3 gallons) capacity.” For the above reasons, NFPA 30 does not apply to PDI products. Please verify these storage requirements against your insurance carrier requirements since they may be more stringent than NFPA 30.

The expiration date is stamped directly on the product. Sani-24® Spray, Sani-Prime® Spray, Sani-Cloth® AF3, Super Sani-Cloth®, Sani-Cloth® Plus, and Sani-Cloth® HB products have a shelf life of 24 months from the date of manufacture. Sani-Cloth® Prime Wipes, Sani-HyPerCide® Spray, and Wipes have a shelf life of 12 months. And, Sani-Cloth® Bleach wipes have a shelf life of 11 months from date of manufacture.
Please NOTE: Product can be used until the expiration date, even after being opened.

Our products are designed to be compatible. Extensive work has been performed on materials and equipment to confirm compatibility. For information on Compatible by Design™, our comprehensive program and resources for improving healthcare equipment compatibility, review our “PDI Material Compatibility Reference Guide”, our resources, and use our Equipment Compatibility Tool to learn more!

Please refer to the surface or equipment manufacturer’s guidelines for approved disinfecting instructions and contact your local PDI representative or Customer Care with any additional questions..

Sani-Cloth, Sani-Prime and Easy Screen products DO NOT carry California Proposition 65 Warning. Proposition 65, officially known as the Safe Drinking Water and Toxic Enforcement Act of 1986, requires the state to maintain and update a list of chemicals known to the state to cause cancer or reproductive toxicity.

The back and forth strokes provide friction which allows for deeper penetration of the antiseptic into the cracks and fissures of the skin in the epidermis.

The following evidence-based clinical guidelines support the use of Chlorhexidine Gluconate/Alcohol for disinfection of needleless access sites prior to use:
1. Guidelines for the Prevention of Intravascular Catheter-Related Infections, US Centers for Disease Control and Prevention (CDC)
2. Standards of Practice, Infusion Nurses Society (INS)
3. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals, Society for Healthcare Epidemiology of America (SHEA)
4. National Patient Safety Goals, The Joint Commission
5. Clinical Practice Guidelines for Diagnosis and Management of Intravascular Catheter-Related Infection, Infectious Disease Society of America (IDSA)
6. Elimination Guide to Infections in Hemodialysis Settings, Association for Professionals in Infection Control and Epidemiology (APIC)

Not necessarily. If clinicians follow all existing infection prevention and control measures, such as hand hygiene, use of personal protective equipment, use of chlorhexidine-based skin antisepsis, etc. then the use of an alcohol impregnated cap may not be clinically indicated. This would be evaluated by ongoing surveillance of HAI rates.